ArticleFrontiers in oncology2018
The Polycomb BMI1 Protein Is Co-expressed With CD26+ in Leukemic Stem Cells of Chronic Myeloid Leukemia.
Registry-linked trialOpen access · goldAbstract read
In one paragraph
Article in Frontiers in oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01860456 (Tyrosine Kinase Inhibitors of BCR/ABL), which is not on this map. Cited by 15 papers.
0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Tyrosine Kinase Inhibitors of BCR/ABL: Pharmacokinetic and Pharmacogenetic Study in Patients Affected by Chronic Myeloid Leukemia. Evaluation of Efficacy and Tolerability
Who cites it
15 citing papers in PubMed, 24 citations in OpenAlex.
- Genetic Variants of BMI1 (rs1042059 and rs11591377) and Their Potential Role in Leukemia Susceptibility: A Narrative Review.Health science reports · 2026Article
- A new digital droplet PCR method for looking at epigenetics in diffuse large B-cell lymphomas: The role of BMI1, EZH2, and USP22 genes.International journal of laboratory hematology · 2025Article
- The biology of chronic myeloid leukemia: an overview of the new insights and biomarkers.Frontiers in oncology · 2025Review
- Cancer stem cells: advances in knowledge and implications for cancer therapy.Signal transduction and targeted therapy · 2024Review
- Prospective monitoring of chronic myeloid leukemia patients from the time of TKI discontinuation: the fate of peripheral blood CD26Frontiers in pharmacology · 2023Article
- CD26/DPP-4 in Chronic Myeloid Leukemia.Cancers · 2022Review
- BCR-ABL1 Tyrosine Kinase Complex Signaling Transduction: Challenges to Overcome Resistance in Chronic Myeloid Leukemia.Pharmaceutics · 2022Review
- Peripheral blood CD26 positive leukemic stem cells as a possible diagnostic and prognostic marker in chronic myeloid leukemia.Leukemia research reports · 2022Article
- Drug resistance and Cancer stem cells.Cell communication and signaling : CCS · 2021Review
- Cancer Stem Cells-Origins and Biomarkers: Perspectives for Targeted Personalized Therapies.Frontiers in immunology · 2020Review
- Tyrosine Kinase Inhibitors Play an Antiviral Action in Patients Affected by Chronic Myeloid Leukemia: A Possible Model Supporting Their Use in the Fight Against SARS-CoV-2.Frontiers in oncology · 2020Article
- Monitoring of Minimal Residual Disease (MRD) in Chronic Myeloid Leukemia: Recent Advances.Cancer management and research · 2020Review
- The WNT Pathway Is Relevant for the BCR-ABL1-Independent Resistance in Chronic Myeloid Leukemia.Frontiers in oncology · 2019Article
- BCR-ABL Independent Mechanisms of Resistance in Chronic Myeloid Leukemia.Frontiers in oncology · 2019Review
- Strategies For Targeting Chronic Myeloid Leukaemia Stem Cells.Blood and lymphatic cancer : targets and therapy · 2019Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
25 authors at 6 institutions in 1 country.
Sara GalimbertiSection of Hematology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Susanna GrassiSection of Hematology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Claudia BaratèSection of Hematology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Francesca GuerriniSection of Hematology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Elena CiabattiSection of Hematology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Francesca PerutelliSection of Hematology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Federica RicciSection of Hematology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Giada Del GenioUnità Operativa Cytogenetics, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
Marina MontaliSection of Hematology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Serena BarachiniSection of Hematology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Cecilia GiulianiUnità Operativa Cytogenetics, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
Maria Immacolata FerreriUnità Operativa Cytogenetics, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
Angelo ValettoUnità Operativa Cytogenetics, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
Elisabetta AbruzzeseUnità Operativa Ematologia, Ospedale S. Eugenio, Rome, Italy.
Chiara IppolitoSection of Histology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Alessandra IurloHematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Monica BocchiaUnità Operativa Ematologia, Università di Siena, Siena, Italy.
Anna SicuranzaUnità Operativa Ematologia, Università di Siena, Siena, Italy.
Bruno MartinoUnità Operativa Ematologia, Ospedale Binco, Melacrino, Morelli, Reggio Calabria, Italy.
Lorenzo IovinoSection of Hematology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Gabriele BudaSection of Hematology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Serena SalehzadehSection of Hematology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Mario PetriniSection of Hematology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Antonello Di PaoloSection of Pharmacology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Letizia MattiiSection of Histology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
University of Pisa · ITAzienda Ospedaliera Universitaria Pisana · ITUniversity of Siena · ITAzienda ospedaliera "Bianchi-Melacrino-Morelli" · ITOspedale Maggiore · ITSt. Eugenio Hospital · IT
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Polycomb gene
Indexed as
BCR-ABL1BMI1CD26CMLleukemic stem cellpolycomb
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
NCT01860456ClinicalTrials.gov
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.